H2AX and cancer: Both AraC and ADM, known as DNA cross-linking agents, act to induce DNA damage in cancer cells [11, 12], manifested by increased S139 phosphorylation of histone H2A.X (designated γH2A.X) at the sites of DNA double-strand break [13].